New CLIA-Waived Tests

Providers can now bill for six new tests (4 drug tests and two lipid/glucose panels) that have been approved by the FDA as waived tests under CLIA. CLIA-waived tests are simple tests performed at the point-of-care using devices that are largely exempt from federal requirements, including most training, proficiency testing, and quality control regulations (unless specified as required in the test system instructions).  In order to be reimbursed for these tests, sites must hold the appropriate CLIA certificate and include their certificate number when submitting test claims. The CPT® codes, effective date, and description for each new test are provided below. Except for procedure 82962, all of the new CLIA-waived tests must have modifier QW added in order to be recognized as a waived test.  

CPT® Code	Effective Date	Test Description
G0434QW	May 29, 2013	SCI International Inc. New Choice At Home Drug Test: Marijuana (Strip Format)
82465QW 83718QW 84478QW 82962	July 1, 2013	Infopia USA, LipidPro® Professional Lipid Profile and Glucose Measuring System
G0434QW	July 29, 2013	Alere iCup DX 14 (Cassette Dip Card format)
G0434QW	September 25, 2013	American Screening Corporation, Inc. Discover Drug Test Cards
G0434QW	September 25, 2013	American Screening Corporation, Inc. Discover Multi-Panel Drug Test Cups
82465QW 83718QW 84478QW 82962	November 12, 2013	Jant Pharmacal Corp, LipidPlus Professional Lipid Profile and Glucose Measuring System